Market News
Recent Developments:
New product Approvals and launches:
- On February 11, 2020, Bluegrass Vascular Technologies, a medical technology company, received a De Novo classification order from the U.S. Food and Drug Administration (FDA) for its Surfacer Inside-Out Access Catheter System. The system is developed to obtain central venous access for catheter insertion into the central venous system for patients with upper body venous occlusions.
- On May 5, 2022, Access Vascular, Inc. (AVI), a manufacturing company of biomaterial-based vascular access devices, announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its HydroPICC Dual-Lumen catheter. Designed and constructed using the same proprietary hydrophilic biomaterial as AVI’s single-lumen HydroPICC and HydroMID catheters. These devices showed significant reduction in complications such as occlusions, replacements, deep vein thrombosis, and phlebitis in studies.
Agreement and partnerships:
- On November 19, 2021, Numedico, a global company in medical technology, signed a global distribution partnership with a medical devices distributor PBC Medicals L.L.C. Numedico. The partnership worth US$ 5.5 million allowed Numedico in distributing their ClickZip Safety Syringe technology into the global markets.
- On May 24, 2021, as part of the national response to COVID-19, the Department of Defense (DOD), in coordination with the Department of Health and Human Services (HHS), signed an agreement with Retractable Technologies, Inc. (RTI), a company manufactures safety medical devices with automated retraction has expand the production of the low dead-space (LDS) safety syringes and needles. The government allocated fund worth US$ 27.3 million.
U.S.: 
U.K. : 
India : 
